A carregar...

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism

BACKGROUND: The calcimimetic agent cinacalcet is effective for the management of secondary hyperparathyroidism (SHPT) in dialysis patients. Changes to reimbursement of cinacalcet in Australia provided an opportunity to assess effects of medication cessation on biochemical and clinical outcomes in di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Main Authors: Ruderman, Irene, Smith, Edward R., Toussaint, Nigel D., Hewitson, Tim D., Holt, Stephen G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952622/
https://ncbi.nlm.nih.gov/pubmed/29764395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0910-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!